Results 111 to 120 of about 8,231 (179)

Signal transduction mechanism of P2-purinergic receptors in thyroid cells.

Japanese Journal of Pharmacology, 1991
Fumikazu Okajima, Hideaki Tomura, Koichi Sato, Martina Nazarea, Kimie Sho, Yoichi Kondo   +5 more
openaire   +1 more source

Purinergic Signaling, HIF, and ROS Interactions in Myocardial I/R Injury: Therapeutic Potential and Future Prospective. [PDF]

Cells
Singh MK, Yun HR, Ranbhise J, Han S, Seo H, Yeo SG, Quan FS, Kim SS, Kang I.   +8 more
europepmc   +1 more source

Role of purinergic activation and TRPC3 channels in the Frank-Starling mechanism. [PDF]

J Physiol Sci
Chiba Y, Kaihara K, Iribe G.
europepmc   +1 more source

The long march towards testing the adenosine receptor agonism hypothesis for human cerebroprotection: The story of the A₁R/A₃R receptor agonist AST-004. [PDF]

Purinergic Signal
Liston TE, Korinek WS, Jacobson KA, Lechleiter JD.   +3 more
europepmc   +1 more source

Latest advances on the role of P2X Receptors in colorectal inflammation and cancer. [PDF]

Purinergic Signal
Ruo L, Fortuna F, Grignolo M, Pegoraro A, Adinolfi E.   +4 more
europepmc   +1 more source

Platelet-Derived Granules and Extracellular Vesicles in Neurodegenerative Diseases: Neurovascular Mechanisms and Clinical Implications. [PDF]

Cells
Lee BK, Yoo JR, Jung YS.
europepmc   +1 more source

Acute effects of a single electroacupuncture session on purinergic signaling and inflammatory markers in patients with chronic nonspecific low back pain: a pilot study. [PDF]

Purinergic Signal
Ecco JC, Ansolin V, Soares AA, Dalagnol AMK, Marafon F, Franscescon F, Bianchini MC, de Resende E Silva DT.   +7 more
europepmc   +1 more source

Adenosine Signaling in Primary and Metastatic Brain Tumors: Immune Suppression, Tumor Progression, and Therapeutic Opportunities. [PDF]

Mol Neurobiol
de Oliveira Lima T, Soares AA, Böhm BR, Teixeira BM, da Costa LCT, Pretto KP, de Souza JVG, da Cunha MLV, Lameu C, Boison D, de Resende eSilva DT.   +10 more
europepmc   +1 more source

Purinergic Signaling in Ovarian Carcinoma. [PDF]

Adv Pharm Bull
Martínez-Ramírez AS, Nuñez-Ríos JD, Juárez-Mercado AP, Campos-Contreras ADR, Vázquez-Cuevas FG.   +4 more
europepmc   +1 more source

Special Issue "Advances in the Prevention and Treatment of Ischemic Diseases". [PDF]

Int J Mol Sci
Plotnikov EY.
europepmc   +1 more source